- Statements regarding the inclusion/exclusion of issues should be clearly supported by scientific evidence, and specifically outline the relevance of the suggested material to the guidelines.
- If you have identified any gaps or errors in the content please suggest suitable text for inclusion.
- Attach any supporting references or newly published evidence to be considered by the author group for inclusion to your comment.
How to post a public comment
- Create a user account and/or log in with your details
- To post a comment, click the blue 'Make a new comment' link below
- Fill in the empty boxes
- Warning: You need to fill out the subject line and box!
- Attach supporting references and any new papers to go with your comment and to be considered by the author group for inclusion by clicking on "Attach academic evidence".
- Press 'save page' to post your comment!
|Thread title||Replies||Last modified|
|What is best practice for documenting and communicating the treatment plan?||0||12:37, 15 June 2017|
This section refers to making the treatment plan available to the patient in a patient friendly format to support shared decision making
My comments here and in a later section will all relate to the omission of the role of the patient and family
Cancer care is delivered in partnership with patients and families and the stronger that partnership, the better the outcomes. By shared decision making, I presume you mean with patients and carers, not just within the clinical team. If so, then I think the patient and carers should be acknowledged as key partners in the delivery of care, with specified role to improve safe delivery and reporting of chemotherapy administration and side effects.
Patient information needs are vast, variable and demanding of health care providers
Outpatient cancer care is now the norm and this means patients and families/carers are key partners in care, and have an important role in ensuring safety of chemotherapy delivery.
I think this warrants a dedicated section in this wiki document, the role of the patient and carer in safe delivery of cancer treatment, from understanding of the rationale for chemotherapy, the documentation they need to keep, (and how to support them in such documentation), the timeliness of feedback to clinical team, the appointment of a care coordinator (nursing, social work, other clinician), appointment of a surrogate decision maker from the outset of care, frequency of relevant and timely reinforcement of information, out of hours processes for reporting of adverse events and the most effective way to report these events to assist health professionals in assessing seriousness of events.